Showing 41 - 60 results of 78 for search '"HAART"', query time: 0.05s Refine Results
  1. 41

    The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection by N. D. Yuschuk, S. L. Maximov, L. M. Ivanova, Ye. K. Klimova, O. O. Znoyko, A. V. Kravchenko

    Published 2009-02-01
    “…Studying of efficacy and safety of the combined therapy of chronic hepatitis C (CHC) by pegilated interferon α-2а in combination to ribavirin at early stages of chronic hepatitis and HIV-infection at patients receiving no high activity antiretroviral therapy (HAART), and comparison of these data with results of treatment of patients with HCV monoinfection.Materials and methods. …”
    Get full text
    Article
  2. 42

    Hemophagocytic Lymphohistiocytosis in an AIDS Patient with Kaposi Sarcoma: A Treatment Dilemma by Oluwadunni E. Emiloju, Sorab Gupta, Vivian Arguello-Guerra, Claudia Dourado

    Published 2019-01-01
    “…We present an unusual case of a patient with AIDS and disseminated Kaposi sarcoma who was commenced on highly active antiretroviral therapy (HAART) but developed HLH secondary to immune reconstitution inflammatory syndrome (IRIS). …”
    Get full text
    Article
  3. 43

    Timing of Antiretroviral Therapy for HIV in the Setting of TB Treatment by Damani A. Piggott, Petros C. Karakousis

    Published 2011-01-01
    “…Highly active antiretroviral therapy (HAART) has been a critical component in combating the scourge of these two conditions as both a preemptive and therapeutic modality. …”
    Get full text
    Article
  4. 44

    Towards Elimination of Mother-to-Child Transmission of HIV: The Impact of a Rapid Results Initiative in Nyanza Province, Kenya by Lisa L. Dillabaugh, Jayne Lewis Kulzer, Kevin Owuor, Valerie Ndege, Arbogast Oyanga, Evelyne Ngugi, Starley B. Shade, Elizabeth Bukusi, Craig R. Cohen

    Published 2012-01-01
    “…HAART uptake in HIV-positive infants remained stable (RR 1.1, 95% CI 0.9–1.4) during the RRI and improved by 30% (RR 1.3, 95% CI 1.0–1.6) post-RRI. …”
    Get full text
    Article
  5. 45

    HIV Treatment in the Criminal Justice System: Critical Knowledge and Intervention Gaps by Jaimie P. Meyer, Nadine E. Chen, Sandra A. Springer

    Published 2011-01-01
    “…Continuity of care is critical for HAART-based prevention of HIV-related morbidity and mortality. …”
    Get full text
    Article
  6. 46

    Arterial Thrombosis in Patients with Human Immunodeficiency Virus: Two-Case Reports and Review of the Literature by C. Konin, J. B. Anzouan-Kacou, A. Essam N'loo

    Published 2011-01-01
    “…Case 1: an HIV infected female presented with sudden loss of consciousness and right hemiplegia. She had been taking HAART regimen for five years. Neck vessels ultrasonography revealed thrombosis on left ICA. …”
    Get full text
    Article
  7. 47

    Burden of Anemia among Human Immunodeficiency Virus-Positive Adults on Highly Active Antiretroviral Therapy at Hawassa University Compressive Specialized Hospital, Hawassa, Ethiopi... by Sisay Tesfaye, Melaku Hirigo, Dawit Jember, Mekdes Shifeta, Worku Ketema

    Published 2023-01-01
    “…A hospital-based retrospective study was conducted among HIV-positive adults on HAART at Hawassa University Compressive Specialized Hospital. …”
    Get full text
    Article
  8. 48
  9. 49

    Hodgkin's Disease in Patients with HIV Infection by Michele Spina, Antonino Carbone, Annunziata Gloghini, Diego Serraino, Massimiliano Berretta, Umberto Tirelli

    Published 2011-01-01
    “…In the lack of randomized trials, several phase II studies have showed that in the era of highly active antiretroviral therapy (HAART) the same regimens employed in HIV-negative patients with HL can be used in HIV setting with similar results. …”
    Get full text
    Article
  10. 50

    A Prospective Study Assessing Tumour Response, Survival, and Palliative Care Outcomes in Patients with HIV-Related Kaposi's Sarcoma at Queen Elizabeth Central Hospital, Blantyre, M... by H. Francis, M. J. Bates, L. Kalilani

    Published 2012-01-01
    “…Vincristine therapy and highly active antiretroviral therapy (HAART) were given. Tumour response, survival, and chemotherapy-related toxicities were documented. …”
    Get full text
    Article
  11. 51

    Quality of Sleep in an HIV Population on Antiretroviral Therapy at an Urban Tertiary Centre in Lagos, Nigeria by Olajumoke Oshinaike, Akinsegun Akinbami, Olaitan Ojelabi, Akinola Dada, Adedoyin Dosunmu, Sarah John Olabode

    Published 2014-01-01
    “…To determine the prevalence of sleep disturbance and its associated characteristics in HIV-positive outpatients on HAART using the PSQI. Methods. Using a cross-sectional design, 300 patients attending the outpatient HIV/AIDS clinic at the Lagos State University Teaching Hospital were recruited. …”
    Get full text
    Article
  12. 52

    Symptomatic Mixed Cryoglobulinemia during HIV Primary Infection: A Case Report by Philippe Genet, Laurence Courdavault, Bouchra Wifaq, Juliette Gerbe

    Published 2011-01-01
    “…Cryoglobulinemia progressively disappeared in several months after HAART.…”
    Get full text
    Article
  13. 53

    Determinants of Anemia among HIV-Positive Children on Highly Active Antiretroviral Therapy Attending Hospitals of North Wollo Zone, Amhara Region, Ethiopia, 2019: A Case-Control St... by Biruk Beletew, Ayelign Mengesha, Mohammed Ahmed, Awet Fitwi, Mesfin Wudu

    Published 2020-01-01
    “…A case-control study was conducted on 350 HIV-infected children on HAART attending Hospitals of North Wollo Zone, from February 1 to March 30, 2019. …”
    Get full text
    Article
  14. 54

    Failure to Control Caries in an AIDS-Affected Individual: A Case Report by Karen A. Nedwick-Castro, Alexandre R. Vieira

    Published 2012-01-01
    “…These patients take numerous medications (HAART: highly active antiretroviral therapy) that cause xerostomia, which increases caries risk. …”
    Get full text
    Article
  15. 55

    Hybrid optimal control for HIV multi-drug therapies: A finite set control transcription approach by Divya Thakur, Belinda Marchand

    Published 2012-09-01
    “…An STI treatment strategy may be beneficial in lowering the risk of HIV mutating to drug-resistant strains, and could provide patients with respite from toxic side effects of HAART. A shorter treatment period is considered compared to previous studies and the solution to the HIV STI problem is obtained via the Finite Set Control Transcription (FSCT) formulation. …”
    Get full text
    Article
  16. 56

    The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance by Mark A. Wainberg

    Published 2012-01-01
    “…The use of highly active antiretroviral therapy (HAART) involves combinations of drugs to achieve maximal virological response and reduce the potential for the emergence of antiviral resistance. …”
    Get full text
    Article
  17. 57

    Mucocutaneous Manifestations of HIV and the Correlation with WHO Clinical Staging in a Tertiary Hospital in Nigeria by Olumayowa Abimbola Oninla

    Published 2014-01-01
    “…Dermatoses can therefore serve as diagnostic and prognostic markers in resource limited settings to initiate HAART in clinical stages 3 and 4.…”
    Get full text
    Article
  18. 58

    AIDS Cholangiopathy in an Asymptomatic, Previously Undiagnosed Late-Stage HIV-Positive Patient from Kenya by Yiming Gao, Kathryn Chin, Yehia Y. Mishriki

    Published 2011-01-01
    “…It is no longer common in countries in which HAART therapy is widely employed but is still seen in underdeveloped countries. …”
    Get full text
    Article
  19. 59

    Pseudogout Associated Hip Pain in a Patient with HIV Infection by Benan M. Dala-Ali, Matthew Welck, Mary Anne Lloyd, Henry D. Atkinson

    Published 2010-01-01
    “…However, it is difficult to fully ascertain whether these conditions are related to the HIV infection itself or the HAART (highly active antiretroviral therapy). There are no previously reported cases of HIV-infected patients with pseudogout. …”
    Get full text
    Article
  20. 60

    Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis by Abigayle Sullivan, Theresa Lanham, Ronald Krol, Shilla Zachariah

    Published 2020-01-01
    “…We describe a rare case of Pneumocystis jirovecii pneumonia (PCP) in a heterosexual man with a pertinent medical history of well-controlled human immunodeficiency virus (HIV) on highly active antiretroviral therapy (HAART) and PCP prophylaxis with atovaquone. The patient presented with recurrent shortness of breath, worsening malaise, and fever, following treatment for hypersensitivity pneumonitis one month prior, including a twenty-four-day course of 40 milligrams daily glucocorticoid with taper. …”
    Get full text
    Article